Ronald M. Goldenberg
Concord, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Tirzepatide Versus Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes With Established Cardiovascular Disease: An Indirect Treatment Comparison Meta-Analysis.
Journal: Diabetes, obesity & metabolism
Published: April 09, 2026
An indirect treatment comparison of tirzepatide 10 and 15 mg versus high-dose semaglutide 7.2 mg in people with obesity and type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: September 29, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada.
Journal: Journal of medical economics
Published: August 25, 2025
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta-analysis of observational studies.
Journal: Diabetes, obesity & metabolism
Published: June 26, 2025
Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials.
Journal: Diabetes, obesity & metabolism
Published: June 18, 2025
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms.
Journal: Current medical research and opinion
Published: January 28, 2025
Perioperative and Periprocedural Management of Once-Weekly Insulin Treated Patients.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: December 04, 2024
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5.
Journal: Diabetes, obesity & metabolism
Published: November 29, 2024
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults---2024 Update: An Opportunity Lost to Move Beyond First-line Metformin.
Journal: Canadian journal of diabetes
Published: November 27, 2024
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1.
Journal: Diabetes research and clinical practice
Published: June 24, 2024
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease.
Journal: Kidney international
Published: April 19, 2024
Last Updated: 09/26/2026